Edwards Redesigns PARTNER Trial, Pushes Back Sapien Approval Timeline
This article was originally published in The Gray Sheet
Executive Summary
Edwards Lifesciences has reached a verbal agreement with FDA on an amended design for the PARTNER trial of its Sapien transcatheter aortic valve, the company announced during its Dec. 7 2007 investor conference